LDXHF vs JNJ: Which Stock is Better?

Side-by-side comparison of Lumos Diagnostics Holdings Limited and Johnson & Johnson in 2026

Comparison Updated:

LDXHF

Lumos Diagnostics Holdings Limited

$0.15

JNJ

Johnson & Johnson

$234.18

Key Metrics Comparison

MetricLDXHFJNJWinner
Market Cap$120.46M$565.22BJNJ
P/E RatioN/A21.26JNJ
EPS (TTM)$N/A$11.03JNJ
Revenue Growth-0.0%0.1%JNJ
Gross Margin62.2%68.0%JNJ

Analyze LDXHF

Full quant analysis

Analyze JNJ

Full quant analysis

Analyze Each Stock

Frequently Asked Questions

Is LDXHF or JNJ a better investment?

Comparing LDXHF and JNJ: Lumos Diagnostics Holdings Limited has a market cap of $120.46M while Johnson & Johnson has $565.22B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.

What is the difference between LDXHF and JNJ?

LDXHF (Lumos Diagnostics Holdings Limited) and JNJ (Johnson & Johnson) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.

Which stock has better value: LDXHF or JNJ?

Based on P/E ratios, compare detailed valuation metrics on our dashboard.

Which is growing faster: LDXHF or JNJ?

JNJ has higher revenue growth at 0.1% vs -0.0% for LDXHF.

Which company is more profitable: LDXHF or JNJ?

Johnson & Johnson (JNJ) has higher gross margins at 68.0% compared to 62.2% for LDXHF.

Which is the larger company: LDXHF or JNJ?

Johnson & Johnson (JNJ) is larger with a market cap of $565.22B compared to $120.46M for LDXHF.

Should I buy LDXHF or JNJ in 2026?

Both LDXHF and JNJ have investment merit. LDXHF trades at $0.15 while JNJ trades at $234.18. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.

What are the key differences between LDXHF and JNJ stock?

Key differences: Market Cap ($120.46M vs $565.22B), P/E Ratio (N/A vs 21.3x), Revenue Growth (-0.0% vs 0.1%), Gross Margin (62.2% vs 68.0%).

Popular Stock Comparisons